Physician profile
Matthew H Griffith
NPI 1033280813
$1,229.96
in general payments reported to CMS, 2019-2025
12 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $34.55 · 2021: $18.22 · 2022: $153 · 2023: $426 · 2024: $180 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $650.32 | 2019-2025 | Healicoil, Bioinductive Implant With Arthroscopic Delivery System - Medium, Na |
| Djo, LLC | $137.51 | 2023 | Donjoy, Procare, Aircast |
| Depuy Synthes Sales INC. | $107.62 | 2019-2025 | Orthovisc, Monovisc, Peak |
| Pacira Pharmaceuticals Incorporated | $100.91 | 2023-2025 | Exparel, Iovera, Zilretta |
| Anika Therapeutics, INC. | $59.39 | 2022 | |
| Stryker Corporation | $38.18 | 2024-2025 | Crossflow, Crossfire, Iconix |
| Fidia Pharma USA INC. | $30.82 | 2022-2025 | Triluron |
| Zimmer Biomet Holdings, INC. | $30.01 | 2024 | A.L.P.S. |
| Solventum Corporation | $23.35 | 2025 | V.A.C. Veraflo, Prevena |
| Ethicon US, LLC | $20.16 | 2024 | Dermabond Prineo, Monocryl, Stratafix |
| Ferring Pharmaceuticals INC. | $18.79 | 2022 | |
| Wright Medical Technology, INC. | $12.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.